Abbott's MDx Sales Rise 21 Percent in Q2 | GenomeWeb

NEW YORK (GenomeWeb News) – Abbott today reported worldwide molecular diagnostics sales of $73 million, up around 21 percent, not including the effects of currency translation, over its 2008 MDx sales.

The Abbott Park, Ill.-based pharmaceuticals and medical products giant said that including the negative effects of foreign exchange its global molecular diagnostic sales were up 11 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.